Global Phenytoin Market

Phenytoin Comprehensive Study by Type (Extend Release Capsule (100 mg, 200 mg and 300 mg), Immediate Release Capsule (30 mg and 100 mg), Chewable Tablet (50 mg), Oral Suspension (125 mg/5mL), Injectable Solution (50 mg/mL)), Application (Seizures, Irregular Heart Beats, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Others), End-user (Hospitals, Clinics, Ambulatory Surgical Centres) Players and Region - Global Market Outlook to 2026

Phenytoin Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Phenytoin Market?

Phenytoin is an anticonvulsant or antiepileptic drug used to prevent and control seizures by reducing the spread of seizure activity in the brain. It helps in treating and preventing seizures that may begin during or after surgery to the brain or nervous system. It may also be used for the treatment of certain types of irregular heartbeats. The factors such as Increased Prevalence of Seizures among People and the Development of New Diagnostic Centres and Hospitals in Developing Regions are the key drivers for the global Phenytoin market. However, Side Effects of the Phenytoin such as Problems with Walking and Co-ordination, Slurred Speech, Confusion and Dizziness may hamper the market growth.

The market study is being classified by Type (Extend Release Capsule (100 mg, 200 mg and 300 mg), Immediate Release Capsule (30 mg and 100 mg), Chewable Tablet (50 mg), Oral Suspension (125 mg/5mL) and Injectable Solution (50 mg/mL)), by Application (Seizures, Irregular Heart Beats and Others) and major geographies with country level break-up.

Actavis Mid-Atlantic, LLC (United States), Pfizer pharmaceuticals Ltd (United States), Sun pharmaceutical industries Ltd (India), Wockhardt Ltd (India), Watson Laboratories, Inc. (United States), Pharmeral Inc (United States), APP Pharmaceuticals, LLC (United States), Baxter International Inc. (United States), Hospira (United States) and Mylan N.V. (United States) are some of the key players profiled in the study.

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Phenytoin market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Phenytoin market by Type, Application and Region.

On the basis of geography, the market of Phenytoin has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increased Prevalence of Seizures among People
  • Development of New Diagnostic Centres and Hospitals in Developing Regions

Market Trend
  • Increased Research and Development Investments

Restraints
  • Side Effects of the Phenytoin such as Problems with Walking and Co-ordination, Slurred Speech, Confusion and Dizziness

Opportunities
  • Growth in the Healthcare Industry Worldwide
  • Investments by Major Players in the Market

Challenges
  • Stringent Government Rules and Regulations





Key Target Audience
Phenytoin Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users

Report Objectives / Segmentation Covered

By Type
  • Extend Release Capsule (100 mg, 200 mg and 300 mg)
  • Immediate Release Capsule (30 mg and 100 mg)
  • Chewable Tablet (50 mg)
  • Oral Suspension (125 mg/5mL)
  • Injectable Solution (50 mg/mL)
By Application
  • Seizures
  • Irregular Heart Beats
  • Others
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online
  • Others

By End-user
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence of Seizures among People
      • 3.2.2. Development of New Diagnostic Centres and Hospitals in Developing Regions
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. Increased Research and Development Investments
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Phenytoin, by Type, Application, Distribution Channel, End-user and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Phenytoin (Value)
      • 5.2.1. Global Phenytoin by: Type (Value)
        • 5.2.1.1. Extend Release Capsule (100 mg, 200 mg and 300 mg)
        • 5.2.1.2. Immediate Release Capsule (30 mg and 100 mg)
        • 5.2.1.3. Chewable Tablet (50 mg)
        • 5.2.1.4. Oral Suspension (125 mg/5mL)
        • 5.2.1.5. Injectable Solution (50 mg/mL)
      • 5.2.2. Global Phenytoin by: Application (Value)
        • 5.2.2.1. Seizures
        • 5.2.2.2. Irregular Heart Beats
        • 5.2.2.3. Others
      • 5.2.3. Global Phenytoin by: Distribution Channel (Value)
        • 5.2.3.1. Hospital Pharmacies
        • 5.2.3.2. Retail Pharmacies
        • 5.2.3.3. Online
        • 5.2.3.4. Others
      • 5.2.4. Global Phenytoin by: End-user (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Clinics
        • 5.2.4.3. Ambulatory Surgical Centres
      • 5.2.5. Global Phenytoin Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Phenytoin (Volume)
      • 5.3.1. Global Phenytoin by: Type (Volume)
        • 5.3.1.1. Extend Release Capsule (100 mg, 200 mg and 300 mg)
        • 5.3.1.2. Immediate Release Capsule (30 mg and 100 mg)
        • 5.3.1.3. Chewable Tablet (50 mg)
        • 5.3.1.4. Oral Suspension (125 mg/5mL)
        • 5.3.1.5. Injectable Solution (50 mg/mL)
      • 5.3.2. Global Phenytoin by: Application (Volume)
        • 5.3.2.1. Seizures
        • 5.3.2.2. Irregular Heart Beats
        • 5.3.2.3. Others
      • 5.3.3. Global Phenytoin by: Distribution Channel (Volume)
        • 5.3.3.1. Hospital Pharmacies
        • 5.3.3.2. Retail Pharmacies
        • 5.3.3.3. Online
        • 5.3.3.4. Others
      • 5.3.4. Global Phenytoin by: End-user (Volume)
        • 5.3.4.1. Hospitals
        • 5.3.4.2. Clinics
        • 5.3.4.3. Ambulatory Surgical Centres
      • 5.3.5. Global Phenytoin Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Phenytoin (Price)
      • 5.4.1. Global Phenytoin by: Type (Price)
  • 6. Phenytoin: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Actavis Mid-Atlantic, LLC (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer pharmaceuticals Ltd (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Sun pharmaceutical industries Ltd (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Wockhardt Ltd (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Watson Laboratories, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Pharmeral Inc (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. APP Pharmaceuticals, LLC (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Baxter International Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Hospira (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Mylan N.V. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Phenytoin Sale, by Type, Application, Distribution Channel, End-user and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Phenytoin (Value)
      • 7.2.1. Global Phenytoin by: Type (Value)
        • 7.2.1.1. Extend Release Capsule (100 mg, 200 mg and 300 mg)
        • 7.2.1.2. Immediate Release Capsule (30 mg and 100 mg)
        • 7.2.1.3. Chewable Tablet (50 mg)
        • 7.2.1.4. Oral Suspension (125 mg/5mL)
        • 7.2.1.5. Injectable Solution (50 mg/mL)
      • 7.2.2. Global Phenytoin by: Application (Value)
        • 7.2.2.1. Seizures
        • 7.2.2.2. Irregular Heart Beats
        • 7.2.2.3. Others
      • 7.2.3. Global Phenytoin by: Distribution Channel (Value)
        • 7.2.3.1. Hospital Pharmacies
        • 7.2.3.2. Retail Pharmacies
        • 7.2.3.3. Online
        • 7.2.3.4. Others
      • 7.2.4. Global Phenytoin by: End-user (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Clinics
        • 7.2.4.3. Ambulatory Surgical Centres
      • 7.2.5. Global Phenytoin Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Phenytoin (Volume)
      • 7.3.1. Global Phenytoin by: Type (Volume)
        • 7.3.1.1. Extend Release Capsule (100 mg, 200 mg and 300 mg)
        • 7.3.1.2. Immediate Release Capsule (30 mg and 100 mg)
        • 7.3.1.3. Chewable Tablet (50 mg)
        • 7.3.1.4. Oral Suspension (125 mg/5mL)
        • 7.3.1.5. Injectable Solution (50 mg/mL)
      • 7.3.2. Global Phenytoin by: Application (Volume)
        • 7.3.2.1. Seizures
        • 7.3.2.2. Irregular Heart Beats
        • 7.3.2.3. Others
      • 7.3.3. Global Phenytoin by: Distribution Channel (Volume)
        • 7.3.3.1. Hospital Pharmacies
        • 7.3.3.2. Retail Pharmacies
        • 7.3.3.3. Online
        • 7.3.3.4. Others
      • 7.3.4. Global Phenytoin by: End-user (Volume)
        • 7.3.4.1. Hospitals
        • 7.3.4.2. Clinics
        • 7.3.4.3. Ambulatory Surgical Centres
      • 7.3.5. Global Phenytoin Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Phenytoin (Price)
      • 7.4.1. Global Phenytoin by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Phenytoin: by Type(USD Million)
  • Table 2. Phenytoin Extend Release Capsule (100 mg, 200 mg and 300 mg) , by Region USD Million (2015-2020)
  • Table 3. Phenytoin Immediate Release Capsule (30 mg and 100 mg) , by Region USD Million (2015-2020)
  • Table 4. Phenytoin Chewable Tablet (50 mg) , by Region USD Million (2015-2020)
  • Table 5. Phenytoin Oral Suspension (125 mg/5mL) , by Region USD Million (2015-2020)
  • Table 6. Phenytoin Injectable Solution (50 mg/mL) , by Region USD Million (2015-2020)
  • Table 7. Phenytoin: by Application(USD Million)
  • Table 8. Phenytoin Seizures , by Region USD Million (2015-2020)
  • Table 9. Phenytoin Irregular Heart Beats , by Region USD Million (2015-2020)
  • Table 10. Phenytoin Others , by Region USD Million (2015-2020)
  • Table 11. Phenytoin: by Distribution Channel(USD Million)
  • Table 12. Phenytoin Hospital Pharmacies , by Region USD Million (2015-2020)
  • Table 13. Phenytoin Retail Pharmacies , by Region USD Million (2015-2020)
  • Table 14. Phenytoin Online , by Region USD Million (2015-2020)
  • Table 15. Phenytoin Others , by Region USD Million (2015-2020)
  • Table 16. Phenytoin: by End-user(USD Million)
  • Table 17. Phenytoin Hospitals , by Region USD Million (2015-2020)
  • Table 18. Phenytoin Clinics , by Region USD Million (2015-2020)
  • Table 19. Phenytoin Ambulatory Surgical Centres , by Region USD Million (2015-2020)
  • Table 20. South America Phenytoin, by Country USD Million (2015-2020)
  • Table 21. South America Phenytoin, by Type USD Million (2015-2020)
  • Table 22. South America Phenytoin, by Application USD Million (2015-2020)
  • Table 23. South America Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 24. South America Phenytoin, by End-user USD Million (2015-2020)
  • Table 25. Brazil Phenytoin, by Type USD Million (2015-2020)
  • Table 26. Brazil Phenytoin, by Application USD Million (2015-2020)
  • Table 27. Brazil Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 28. Brazil Phenytoin, by End-user USD Million (2015-2020)
  • Table 29. Argentina Phenytoin, by Type USD Million (2015-2020)
  • Table 30. Argentina Phenytoin, by Application USD Million (2015-2020)
  • Table 31. Argentina Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 32. Argentina Phenytoin, by End-user USD Million (2015-2020)
  • Table 33. Rest of South America Phenytoin, by Type USD Million (2015-2020)
  • Table 34. Rest of South America Phenytoin, by Application USD Million (2015-2020)
  • Table 35. Rest of South America Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 36. Rest of South America Phenytoin, by End-user USD Million (2015-2020)
  • Table 37. Asia Pacific Phenytoin, by Country USD Million (2015-2020)
  • Table 38. Asia Pacific Phenytoin, by Type USD Million (2015-2020)
  • Table 39. Asia Pacific Phenytoin, by Application USD Million (2015-2020)
  • Table 40. Asia Pacific Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 41. Asia Pacific Phenytoin, by End-user USD Million (2015-2020)
  • Table 42. China Phenytoin, by Type USD Million (2015-2020)
  • Table 43. China Phenytoin, by Application USD Million (2015-2020)
  • Table 44. China Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 45. China Phenytoin, by End-user USD Million (2015-2020)
  • Table 46. Japan Phenytoin, by Type USD Million (2015-2020)
  • Table 47. Japan Phenytoin, by Application USD Million (2015-2020)
  • Table 48. Japan Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 49. Japan Phenytoin, by End-user USD Million (2015-2020)
  • Table 50. India Phenytoin, by Type USD Million (2015-2020)
  • Table 51. India Phenytoin, by Application USD Million (2015-2020)
  • Table 52. India Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 53. India Phenytoin, by End-user USD Million (2015-2020)
  • Table 54. South Korea Phenytoin, by Type USD Million (2015-2020)
  • Table 55. South Korea Phenytoin, by Application USD Million (2015-2020)
  • Table 56. South Korea Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 57. South Korea Phenytoin, by End-user USD Million (2015-2020)
  • Table 58. Taiwan Phenytoin, by Type USD Million (2015-2020)
  • Table 59. Taiwan Phenytoin, by Application USD Million (2015-2020)
  • Table 60. Taiwan Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 61. Taiwan Phenytoin, by End-user USD Million (2015-2020)
  • Table 62. Australia Phenytoin, by Type USD Million (2015-2020)
  • Table 63. Australia Phenytoin, by Application USD Million (2015-2020)
  • Table 64. Australia Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 65. Australia Phenytoin, by End-user USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Phenytoin, by Type USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Phenytoin, by Application USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 69. Rest of Asia-Pacific Phenytoin, by End-user USD Million (2015-2020)
  • Table 70. Europe Phenytoin, by Country USD Million (2015-2020)
  • Table 71. Europe Phenytoin, by Type USD Million (2015-2020)
  • Table 72. Europe Phenytoin, by Application USD Million (2015-2020)
  • Table 73. Europe Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 74. Europe Phenytoin, by End-user USD Million (2015-2020)
  • Table 75. Germany Phenytoin, by Type USD Million (2015-2020)
  • Table 76. Germany Phenytoin, by Application USD Million (2015-2020)
  • Table 77. Germany Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 78. Germany Phenytoin, by End-user USD Million (2015-2020)
  • Table 79. France Phenytoin, by Type USD Million (2015-2020)
  • Table 80. France Phenytoin, by Application USD Million (2015-2020)
  • Table 81. France Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 82. France Phenytoin, by End-user USD Million (2015-2020)
  • Table 83. Italy Phenytoin, by Type USD Million (2015-2020)
  • Table 84. Italy Phenytoin, by Application USD Million (2015-2020)
  • Table 85. Italy Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 86. Italy Phenytoin, by End-user USD Million (2015-2020)
  • Table 87. United Kingdom Phenytoin, by Type USD Million (2015-2020)
  • Table 88. United Kingdom Phenytoin, by Application USD Million (2015-2020)
  • Table 89. United Kingdom Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 90. United Kingdom Phenytoin, by End-user USD Million (2015-2020)
  • Table 91. Netherlands Phenytoin, by Type USD Million (2015-2020)
  • Table 92. Netherlands Phenytoin, by Application USD Million (2015-2020)
  • Table 93. Netherlands Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 94. Netherlands Phenytoin, by End-user USD Million (2015-2020)
  • Table 95. Rest of Europe Phenytoin, by Type USD Million (2015-2020)
  • Table 96. Rest of Europe Phenytoin, by Application USD Million (2015-2020)
  • Table 97. Rest of Europe Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 98. Rest of Europe Phenytoin, by End-user USD Million (2015-2020)
  • Table 99. MEA Phenytoin, by Country USD Million (2015-2020)
  • Table 100. MEA Phenytoin, by Type USD Million (2015-2020)
  • Table 101. MEA Phenytoin, by Application USD Million (2015-2020)
  • Table 102. MEA Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 103. MEA Phenytoin, by End-user USD Million (2015-2020)
  • Table 104. Middle East Phenytoin, by Type USD Million (2015-2020)
  • Table 105. Middle East Phenytoin, by Application USD Million (2015-2020)
  • Table 106. Middle East Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 107. Middle East Phenytoin, by End-user USD Million (2015-2020)
  • Table 108. Africa Phenytoin, by Type USD Million (2015-2020)
  • Table 109. Africa Phenytoin, by Application USD Million (2015-2020)
  • Table 110. Africa Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 111. Africa Phenytoin, by End-user USD Million (2015-2020)
  • Table 112. North America Phenytoin, by Country USD Million (2015-2020)
  • Table 113. North America Phenytoin, by Type USD Million (2015-2020)
  • Table 114. North America Phenytoin, by Application USD Million (2015-2020)
  • Table 115. North America Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 116. North America Phenytoin, by End-user USD Million (2015-2020)
  • Table 117. United States Phenytoin, by Type USD Million (2015-2020)
  • Table 118. United States Phenytoin, by Application USD Million (2015-2020)
  • Table 119. United States Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 120. United States Phenytoin, by End-user USD Million (2015-2020)
  • Table 121. Canada Phenytoin, by Type USD Million (2015-2020)
  • Table 122. Canada Phenytoin, by Application USD Million (2015-2020)
  • Table 123. Canada Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 124. Canada Phenytoin, by End-user USD Million (2015-2020)
  • Table 125. Mexico Phenytoin, by Type USD Million (2015-2020)
  • Table 126. Mexico Phenytoin, by Application USD Million (2015-2020)
  • Table 127. Mexico Phenytoin, by Distribution Channel USD Million (2015-2020)
  • Table 128. Mexico Phenytoin, by End-user USD Million (2015-2020)
  • Table 129. Phenytoin Sales: by Type(K Units)
  • Table 130. Phenytoin Sales Extend Release Capsule (100 mg, 200 mg and 300 mg) , by Region K Units (2015-2020)
  • Table 131. Phenytoin Sales Immediate Release Capsule (30 mg and 100 mg) , by Region K Units (2015-2020)
  • Table 132. Phenytoin Sales Chewable Tablet (50 mg) , by Region K Units (2015-2020)
  • Table 133. Phenytoin Sales Oral Suspension (125 mg/5mL) , by Region K Units (2015-2020)
  • Table 134. Phenytoin Sales Injectable Solution (50 mg/mL) , by Region K Units (2015-2020)
  • Table 135. Phenytoin Sales: by Application(K Units)
  • Table 136. Phenytoin Sales Seizures , by Region K Units (2015-2020)
  • Table 137. Phenytoin Sales Irregular Heart Beats , by Region K Units (2015-2020)
  • Table 138. Phenytoin Sales Others , by Region K Units (2015-2020)
  • Table 139. Phenytoin Sales: by Distribution Channel(K Units)
  • Table 140. Phenytoin Sales Hospital Pharmacies , by Region K Units (2015-2020)
  • Table 141. Phenytoin Sales Retail Pharmacies , by Region K Units (2015-2020)
  • Table 142. Phenytoin Sales Online , by Region K Units (2015-2020)
  • Table 143. Phenytoin Sales Others , by Region K Units (2015-2020)
  • Table 144. Phenytoin Sales: by End-user(K Units)
  • Table 145. Phenytoin Sales Hospitals , by Region K Units (2015-2020)
  • Table 146. Phenytoin Sales Clinics , by Region K Units (2015-2020)
  • Table 147. Phenytoin Sales Ambulatory Surgical Centres , by Region K Units (2015-2020)
  • Table 148. South America Phenytoin Sales, by Country K Units (2015-2020)
  • Table 149. South America Phenytoin Sales, by Type K Units (2015-2020)
  • Table 150. South America Phenytoin Sales, by Application K Units (2015-2020)
  • Table 151. South America Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 152. South America Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 153. Brazil Phenytoin Sales, by Type K Units (2015-2020)
  • Table 154. Brazil Phenytoin Sales, by Application K Units (2015-2020)
  • Table 155. Brazil Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 156. Brazil Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 157. Argentina Phenytoin Sales, by Type K Units (2015-2020)
  • Table 158. Argentina Phenytoin Sales, by Application K Units (2015-2020)
  • Table 159. Argentina Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 160. Argentina Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 161. Rest of South America Phenytoin Sales, by Type K Units (2015-2020)
  • Table 162. Rest of South America Phenytoin Sales, by Application K Units (2015-2020)
  • Table 163. Rest of South America Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 164. Rest of South America Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 165. Asia Pacific Phenytoin Sales, by Country K Units (2015-2020)
  • Table 166. Asia Pacific Phenytoin Sales, by Type K Units (2015-2020)
  • Table 167. Asia Pacific Phenytoin Sales, by Application K Units (2015-2020)
  • Table 168. Asia Pacific Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 169. Asia Pacific Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 170. China Phenytoin Sales, by Type K Units (2015-2020)
  • Table 171. China Phenytoin Sales, by Application K Units (2015-2020)
  • Table 172. China Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 173. China Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 174. Japan Phenytoin Sales, by Type K Units (2015-2020)
  • Table 175. Japan Phenytoin Sales, by Application K Units (2015-2020)
  • Table 176. Japan Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 177. Japan Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 178. India Phenytoin Sales, by Type K Units (2015-2020)
  • Table 179. India Phenytoin Sales, by Application K Units (2015-2020)
  • Table 180. India Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 181. India Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 182. South Korea Phenytoin Sales, by Type K Units (2015-2020)
  • Table 183. South Korea Phenytoin Sales, by Application K Units (2015-2020)
  • Table 184. South Korea Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 185. South Korea Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 186. Taiwan Phenytoin Sales, by Type K Units (2015-2020)
  • Table 187. Taiwan Phenytoin Sales, by Application K Units (2015-2020)
  • Table 188. Taiwan Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 189. Taiwan Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 190. Australia Phenytoin Sales, by Type K Units (2015-2020)
  • Table 191. Australia Phenytoin Sales, by Application K Units (2015-2020)
  • Table 192. Australia Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 193. Australia Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 194. Rest of Asia-Pacific Phenytoin Sales, by Type K Units (2015-2020)
  • Table 195. Rest of Asia-Pacific Phenytoin Sales, by Application K Units (2015-2020)
  • Table 196. Rest of Asia-Pacific Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 197. Rest of Asia-Pacific Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 198. Europe Phenytoin Sales, by Country K Units (2015-2020)
  • Table 199. Europe Phenytoin Sales, by Type K Units (2015-2020)
  • Table 200. Europe Phenytoin Sales, by Application K Units (2015-2020)
  • Table 201. Europe Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 202. Europe Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 203. Germany Phenytoin Sales, by Type K Units (2015-2020)
  • Table 204. Germany Phenytoin Sales, by Application K Units (2015-2020)
  • Table 205. Germany Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 206. Germany Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 207. France Phenytoin Sales, by Type K Units (2015-2020)
  • Table 208. France Phenytoin Sales, by Application K Units (2015-2020)
  • Table 209. France Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 210. France Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 211. Italy Phenytoin Sales, by Type K Units (2015-2020)
  • Table 212. Italy Phenytoin Sales, by Application K Units (2015-2020)
  • Table 213. Italy Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 214. Italy Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 215. United Kingdom Phenytoin Sales, by Type K Units (2015-2020)
  • Table 216. United Kingdom Phenytoin Sales, by Application K Units (2015-2020)
  • Table 217. United Kingdom Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 218. United Kingdom Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 219. Netherlands Phenytoin Sales, by Type K Units (2015-2020)
  • Table 220. Netherlands Phenytoin Sales, by Application K Units (2015-2020)
  • Table 221. Netherlands Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 222. Netherlands Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 223. Rest of Europe Phenytoin Sales, by Type K Units (2015-2020)
  • Table 224. Rest of Europe Phenytoin Sales, by Application K Units (2015-2020)
  • Table 225. Rest of Europe Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 226. Rest of Europe Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 227. MEA Phenytoin Sales, by Country K Units (2015-2020)
  • Table 228. MEA Phenytoin Sales, by Type K Units (2015-2020)
  • Table 229. MEA Phenytoin Sales, by Application K Units (2015-2020)
  • Table 230. MEA Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 231. MEA Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 232. Middle East Phenytoin Sales, by Type K Units (2015-2020)
  • Table 233. Middle East Phenytoin Sales, by Application K Units (2015-2020)
  • Table 234. Middle East Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 235. Middle East Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 236. Africa Phenytoin Sales, by Type K Units (2015-2020)
  • Table 237. Africa Phenytoin Sales, by Application K Units (2015-2020)
  • Table 238. Africa Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 239. Africa Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 240. North America Phenytoin Sales, by Country K Units (2015-2020)
  • Table 241. North America Phenytoin Sales, by Type K Units (2015-2020)
  • Table 242. North America Phenytoin Sales, by Application K Units (2015-2020)
  • Table 243. North America Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 244. North America Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 245. United States Phenytoin Sales, by Type K Units (2015-2020)
  • Table 246. United States Phenytoin Sales, by Application K Units (2015-2020)
  • Table 247. United States Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 248. United States Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 249. Canada Phenytoin Sales, by Type K Units (2015-2020)
  • Table 250. Canada Phenytoin Sales, by Application K Units (2015-2020)
  • Table 251. Canada Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 252. Canada Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 253. Mexico Phenytoin Sales, by Type K Units (2015-2020)
  • Table 254. Mexico Phenytoin Sales, by Application K Units (2015-2020)
  • Table 255. Mexico Phenytoin Sales, by Distribution Channel K Units (2015-2020)
  • Table 256. Mexico Phenytoin Sales, by End-user K Units (2015-2020)
  • Table 257. Phenytoin: by Type(USD/Units)
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Phenytoin: by Type(USD Million)
  • Table 269. Phenytoin Extend Release Capsule (100 mg, 200 mg and 300 mg) , by Region USD Million (2021-2026)
  • Table 270. Phenytoin Immediate Release Capsule (30 mg and 100 mg) , by Region USD Million (2021-2026)
  • Table 271. Phenytoin Chewable Tablet (50 mg) , by Region USD Million (2021-2026)
  • Table 272. Phenytoin Oral Suspension (125 mg/5mL) , by Region USD Million (2021-2026)
  • Table 273. Phenytoin Injectable Solution (50 mg/mL) , by Region USD Million (2021-2026)
  • Table 274. Phenytoin: by Application(USD Million)
  • Table 275. Phenytoin Seizures , by Region USD Million (2021-2026)
  • Table 276. Phenytoin Irregular Heart Beats , by Region USD Million (2021-2026)
  • Table 277. Phenytoin Others , by Region USD Million (2021-2026)
  • Table 278. Phenytoin: by Distribution Channel(USD Million)
  • Table 279. Phenytoin Hospital Pharmacies , by Region USD Million (2021-2026)
  • Table 280. Phenytoin Retail Pharmacies , by Region USD Million (2021-2026)
  • Table 281. Phenytoin Online , by Region USD Million (2021-2026)
  • Table 282. Phenytoin Others , by Region USD Million (2021-2026)
  • Table 283. Phenytoin: by End-user(USD Million)
  • Table 284. Phenytoin Hospitals , by Region USD Million (2021-2026)
  • Table 285. Phenytoin Clinics , by Region USD Million (2021-2026)
  • Table 286. Phenytoin Ambulatory Surgical Centres , by Region USD Million (2021-2026)
  • Table 287. South America Phenytoin, by Country USD Million (2021-2026)
  • Table 288. South America Phenytoin, by Type USD Million (2021-2026)
  • Table 289. South America Phenytoin, by Application USD Million (2021-2026)
  • Table 290. South America Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 291. South America Phenytoin, by End-user USD Million (2021-2026)
  • Table 292. Brazil Phenytoin, by Type USD Million (2021-2026)
  • Table 293. Brazil Phenytoin, by Application USD Million (2021-2026)
  • Table 294. Brazil Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 295. Brazil Phenytoin, by End-user USD Million (2021-2026)
  • Table 296. Argentina Phenytoin, by Type USD Million (2021-2026)
  • Table 297. Argentina Phenytoin, by Application USD Million (2021-2026)
  • Table 298. Argentina Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 299. Argentina Phenytoin, by End-user USD Million (2021-2026)
  • Table 300. Rest of South America Phenytoin, by Type USD Million (2021-2026)
  • Table 301. Rest of South America Phenytoin, by Application USD Million (2021-2026)
  • Table 302. Rest of South America Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 303. Rest of South America Phenytoin, by End-user USD Million (2021-2026)
  • Table 304. Asia Pacific Phenytoin, by Country USD Million (2021-2026)
  • Table 305. Asia Pacific Phenytoin, by Type USD Million (2021-2026)
  • Table 306. Asia Pacific Phenytoin, by Application USD Million (2021-2026)
  • Table 307. Asia Pacific Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 308. Asia Pacific Phenytoin, by End-user USD Million (2021-2026)
  • Table 309. China Phenytoin, by Type USD Million (2021-2026)
  • Table 310. China Phenytoin, by Application USD Million (2021-2026)
  • Table 311. China Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 312. China Phenytoin, by End-user USD Million (2021-2026)
  • Table 313. Japan Phenytoin, by Type USD Million (2021-2026)
  • Table 314. Japan Phenytoin, by Application USD Million (2021-2026)
  • Table 315. Japan Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 316. Japan Phenytoin, by End-user USD Million (2021-2026)
  • Table 317. India Phenytoin, by Type USD Million (2021-2026)
  • Table 318. India Phenytoin, by Application USD Million (2021-2026)
  • Table 319. India Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 320. India Phenytoin, by End-user USD Million (2021-2026)
  • Table 321. South Korea Phenytoin, by Type USD Million (2021-2026)
  • Table 322. South Korea Phenytoin, by Application USD Million (2021-2026)
  • Table 323. South Korea Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 324. South Korea Phenytoin, by End-user USD Million (2021-2026)
  • Table 325. Taiwan Phenytoin, by Type USD Million (2021-2026)
  • Table 326. Taiwan Phenytoin, by Application USD Million (2021-2026)
  • Table 327. Taiwan Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 328. Taiwan Phenytoin, by End-user USD Million (2021-2026)
  • Table 329. Australia Phenytoin, by Type USD Million (2021-2026)
  • Table 330. Australia Phenytoin, by Application USD Million (2021-2026)
  • Table 331. Australia Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 332. Australia Phenytoin, by End-user USD Million (2021-2026)
  • Table 333. Rest of Asia-Pacific Phenytoin, by Type USD Million (2021-2026)
  • Table 334. Rest of Asia-Pacific Phenytoin, by Application USD Million (2021-2026)
  • Table 335. Rest of Asia-Pacific Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 336. Rest of Asia-Pacific Phenytoin, by End-user USD Million (2021-2026)
  • Table 337. Europe Phenytoin, by Country USD Million (2021-2026)
  • Table 338. Europe Phenytoin, by Type USD Million (2021-2026)
  • Table 339. Europe Phenytoin, by Application USD Million (2021-2026)
  • Table 340. Europe Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 341. Europe Phenytoin, by End-user USD Million (2021-2026)
  • Table 342. Germany Phenytoin, by Type USD Million (2021-2026)
  • Table 343. Germany Phenytoin, by Application USD Million (2021-2026)
  • Table 344. Germany Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 345. Germany Phenytoin, by End-user USD Million (2021-2026)
  • Table 346. France Phenytoin, by Type USD Million (2021-2026)
  • Table 347. France Phenytoin, by Application USD Million (2021-2026)
  • Table 348. France Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 349. France Phenytoin, by End-user USD Million (2021-2026)
  • Table 350. Italy Phenytoin, by Type USD Million (2021-2026)
  • Table 351. Italy Phenytoin, by Application USD Million (2021-2026)
  • Table 352. Italy Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 353. Italy Phenytoin, by End-user USD Million (2021-2026)
  • Table 354. United Kingdom Phenytoin, by Type USD Million (2021-2026)
  • Table 355. United Kingdom Phenytoin, by Application USD Million (2021-2026)
  • Table 356. United Kingdom Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 357. United Kingdom Phenytoin, by End-user USD Million (2021-2026)
  • Table 358. Netherlands Phenytoin, by Type USD Million (2021-2026)
  • Table 359. Netherlands Phenytoin, by Application USD Million (2021-2026)
  • Table 360. Netherlands Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 361. Netherlands Phenytoin, by End-user USD Million (2021-2026)
  • Table 362. Rest of Europe Phenytoin, by Type USD Million (2021-2026)
  • Table 363. Rest of Europe Phenytoin, by Application USD Million (2021-2026)
  • Table 364. Rest of Europe Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 365. Rest of Europe Phenytoin, by End-user USD Million (2021-2026)
  • Table 366. MEA Phenytoin, by Country USD Million (2021-2026)
  • Table 367. MEA Phenytoin, by Type USD Million (2021-2026)
  • Table 368. MEA Phenytoin, by Application USD Million (2021-2026)
  • Table 369. MEA Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 370. MEA Phenytoin, by End-user USD Million (2021-2026)
  • Table 371. Middle East Phenytoin, by Type USD Million (2021-2026)
  • Table 372. Middle East Phenytoin, by Application USD Million (2021-2026)
  • Table 373. Middle East Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 374. Middle East Phenytoin, by End-user USD Million (2021-2026)
  • Table 375. Africa Phenytoin, by Type USD Million (2021-2026)
  • Table 376. Africa Phenytoin, by Application USD Million (2021-2026)
  • Table 377. Africa Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 378. Africa Phenytoin, by End-user USD Million (2021-2026)
  • Table 379. North America Phenytoin, by Country USD Million (2021-2026)
  • Table 380. North America Phenytoin, by Type USD Million (2021-2026)
  • Table 381. North America Phenytoin, by Application USD Million (2021-2026)
  • Table 382. North America Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 383. North America Phenytoin, by End-user USD Million (2021-2026)
  • Table 384. United States Phenytoin, by Type USD Million (2021-2026)
  • Table 385. United States Phenytoin, by Application USD Million (2021-2026)
  • Table 386. United States Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 387. United States Phenytoin, by End-user USD Million (2021-2026)
  • Table 388. Canada Phenytoin, by Type USD Million (2021-2026)
  • Table 389. Canada Phenytoin, by Application USD Million (2021-2026)
  • Table 390. Canada Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 391. Canada Phenytoin, by End-user USD Million (2021-2026)
  • Table 392. Mexico Phenytoin, by Type USD Million (2021-2026)
  • Table 393. Mexico Phenytoin, by Application USD Million (2021-2026)
  • Table 394. Mexico Phenytoin, by Distribution Channel USD Million (2021-2026)
  • Table 395. Mexico Phenytoin, by End-user USD Million (2021-2026)
  • Table 396. Phenytoin Sales: by Type(K Units)
  • Table 397. Phenytoin Sales Extend Release Capsule (100 mg, 200 mg and 300 mg) , by Region K Units (2021-2026)
  • Table 398. Phenytoin Sales Immediate Release Capsule (30 mg and 100 mg) , by Region K Units (2021-2026)
  • Table 399. Phenytoin Sales Chewable Tablet (50 mg) , by Region K Units (2021-2026)
  • Table 400. Phenytoin Sales Oral Suspension (125 mg/5mL) , by Region K Units (2021-2026)
  • Table 401. Phenytoin Sales Injectable Solution (50 mg/mL) , by Region K Units (2021-2026)
  • Table 402. Phenytoin Sales: by Application(K Units)
  • Table 403. Phenytoin Sales Seizures , by Region K Units (2021-2026)
  • Table 404. Phenytoin Sales Irregular Heart Beats , by Region K Units (2021-2026)
  • Table 405. Phenytoin Sales Others , by Region K Units (2021-2026)
  • Table 406. Phenytoin Sales: by Distribution Channel(K Units)
  • Table 407. Phenytoin Sales Hospital Pharmacies , by Region K Units (2021-2026)
  • Table 408. Phenytoin Sales Retail Pharmacies , by Region K Units (2021-2026)
  • Table 409. Phenytoin Sales Online , by Region K Units (2021-2026)
  • Table 410. Phenytoin Sales Others , by Region K Units (2021-2026)
  • Table 411. Phenytoin Sales: by End-user(K Units)
  • Table 412. Phenytoin Sales Hospitals , by Region K Units (2021-2026)
  • Table 413. Phenytoin Sales Clinics , by Region K Units (2021-2026)
  • Table 414. Phenytoin Sales Ambulatory Surgical Centres , by Region K Units (2021-2026)
  • Table 415. South America Phenytoin Sales, by Country K Units (2021-2026)
  • Table 416. South America Phenytoin Sales, by Type K Units (2021-2026)
  • Table 417. South America Phenytoin Sales, by Application K Units (2021-2026)
  • Table 418. South America Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 419. South America Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 420. Brazil Phenytoin Sales, by Type K Units (2021-2026)
  • Table 421. Brazil Phenytoin Sales, by Application K Units (2021-2026)
  • Table 422. Brazil Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 423. Brazil Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 424. Argentina Phenytoin Sales, by Type K Units (2021-2026)
  • Table 425. Argentina Phenytoin Sales, by Application K Units (2021-2026)
  • Table 426. Argentina Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 427. Argentina Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 428. Rest of South America Phenytoin Sales, by Type K Units (2021-2026)
  • Table 429. Rest of South America Phenytoin Sales, by Application K Units (2021-2026)
  • Table 430. Rest of South America Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 431. Rest of South America Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 432. Asia Pacific Phenytoin Sales, by Country K Units (2021-2026)
  • Table 433. Asia Pacific Phenytoin Sales, by Type K Units (2021-2026)
  • Table 434. Asia Pacific Phenytoin Sales, by Application K Units (2021-2026)
  • Table 435. Asia Pacific Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 436. Asia Pacific Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 437. China Phenytoin Sales, by Type K Units (2021-2026)
  • Table 438. China Phenytoin Sales, by Application K Units (2021-2026)
  • Table 439. China Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 440. China Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 441. Japan Phenytoin Sales, by Type K Units (2021-2026)
  • Table 442. Japan Phenytoin Sales, by Application K Units (2021-2026)
  • Table 443. Japan Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 444. Japan Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 445. India Phenytoin Sales, by Type K Units (2021-2026)
  • Table 446. India Phenytoin Sales, by Application K Units (2021-2026)
  • Table 447. India Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 448. India Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 449. South Korea Phenytoin Sales, by Type K Units (2021-2026)
  • Table 450. South Korea Phenytoin Sales, by Application K Units (2021-2026)
  • Table 451. South Korea Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 452. South Korea Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 453. Taiwan Phenytoin Sales, by Type K Units (2021-2026)
  • Table 454. Taiwan Phenytoin Sales, by Application K Units (2021-2026)
  • Table 455. Taiwan Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 456. Taiwan Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 457. Australia Phenytoin Sales, by Type K Units (2021-2026)
  • Table 458. Australia Phenytoin Sales, by Application K Units (2021-2026)
  • Table 459. Australia Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 460. Australia Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 461. Rest of Asia-Pacific Phenytoin Sales, by Type K Units (2021-2026)
  • Table 462. Rest of Asia-Pacific Phenytoin Sales, by Application K Units (2021-2026)
  • Table 463. Rest of Asia-Pacific Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 464. Rest of Asia-Pacific Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 465. Europe Phenytoin Sales, by Country K Units (2021-2026)
  • Table 466. Europe Phenytoin Sales, by Type K Units (2021-2026)
  • Table 467. Europe Phenytoin Sales, by Application K Units (2021-2026)
  • Table 468. Europe Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 469. Europe Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 470. Germany Phenytoin Sales, by Type K Units (2021-2026)
  • Table 471. Germany Phenytoin Sales, by Application K Units (2021-2026)
  • Table 472. Germany Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 473. Germany Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 474. France Phenytoin Sales, by Type K Units (2021-2026)
  • Table 475. France Phenytoin Sales, by Application K Units (2021-2026)
  • Table 476. France Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 477. France Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 478. Italy Phenytoin Sales, by Type K Units (2021-2026)
  • Table 479. Italy Phenytoin Sales, by Application K Units (2021-2026)
  • Table 480. Italy Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 481. Italy Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 482. United Kingdom Phenytoin Sales, by Type K Units (2021-2026)
  • Table 483. United Kingdom Phenytoin Sales, by Application K Units (2021-2026)
  • Table 484. United Kingdom Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 485. United Kingdom Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 486. Netherlands Phenytoin Sales, by Type K Units (2021-2026)
  • Table 487. Netherlands Phenytoin Sales, by Application K Units (2021-2026)
  • Table 488. Netherlands Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 489. Netherlands Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 490. Rest of Europe Phenytoin Sales, by Type K Units (2021-2026)
  • Table 491. Rest of Europe Phenytoin Sales, by Application K Units (2021-2026)
  • Table 492. Rest of Europe Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 493. Rest of Europe Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 494. MEA Phenytoin Sales, by Country K Units (2021-2026)
  • Table 495. MEA Phenytoin Sales, by Type K Units (2021-2026)
  • Table 496. MEA Phenytoin Sales, by Application K Units (2021-2026)
  • Table 497. MEA Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 498. MEA Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 499. Middle East Phenytoin Sales, by Type K Units (2021-2026)
  • Table 500. Middle East Phenytoin Sales, by Application K Units (2021-2026)
  • Table 501. Middle East Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 502. Middle East Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 503. Africa Phenytoin Sales, by Type K Units (2021-2026)
  • Table 504. Africa Phenytoin Sales, by Application K Units (2021-2026)
  • Table 505. Africa Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 506. Africa Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 507. North America Phenytoin Sales, by Country K Units (2021-2026)
  • Table 508. North America Phenytoin Sales, by Type K Units (2021-2026)
  • Table 509. North America Phenytoin Sales, by Application K Units (2021-2026)
  • Table 510. North America Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 511. North America Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 512. United States Phenytoin Sales, by Type K Units (2021-2026)
  • Table 513. United States Phenytoin Sales, by Application K Units (2021-2026)
  • Table 514. United States Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 515. United States Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 516. Canada Phenytoin Sales, by Type K Units (2021-2026)
  • Table 517. Canada Phenytoin Sales, by Application K Units (2021-2026)
  • Table 518. Canada Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 519. Canada Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 520. Mexico Phenytoin Sales, by Type K Units (2021-2026)
  • Table 521. Mexico Phenytoin Sales, by Application K Units (2021-2026)
  • Table 522. Mexico Phenytoin Sales, by Distribution Channel K Units (2021-2026)
  • Table 523. Mexico Phenytoin Sales, by End-user K Units (2021-2026)
  • Table 524. Phenytoin: by Type(USD/Units)
  • Table 525. Research Programs/Design for This Report
  • Table 526. Key Data Information from Secondary Sources
  • Table 527. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Phenytoin: by Type USD Million (2015-2020)
  • Figure 5. Global Phenytoin: by Application USD Million (2015-2020)
  • Figure 6. Global Phenytoin: by Distribution Channel USD Million (2015-2020)
  • Figure 7. Global Phenytoin: by End-user USD Million (2015-2020)
  • Figure 8. South America Phenytoin Share (%), by Country
  • Figure 9. Asia Pacific Phenytoin Share (%), by Country
  • Figure 10. Europe Phenytoin Share (%), by Country
  • Figure 11. MEA Phenytoin Share (%), by Country
  • Figure 12. North America Phenytoin Share (%), by Country
  • Figure 13. Global Phenytoin: by Type K Units (2015-2020)
  • Figure 14. Global Phenytoin: by Application K Units (2015-2020)
  • Figure 15. Global Phenytoin: by Distribution Channel K Units (2015-2020)
  • Figure 16. Global Phenytoin: by End-user K Units (2015-2020)
  • Figure 17. South America Phenytoin Share (%), by Country
  • Figure 18. Asia Pacific Phenytoin Share (%), by Country
  • Figure 19. Europe Phenytoin Share (%), by Country
  • Figure 20. MEA Phenytoin Share (%), by Country
  • Figure 21. North America Phenytoin Share (%), by Country
  • Figure 22. Global Phenytoin: by Type USD/Units (2015-2020)
  • Figure 23. Global Phenytoin share by Players 2020 (%)
  • Figure 24. Global Phenytoin share by Players (Top 3) 2020(%)
  • Figure 25. Global Phenytoin share by Players (Top 5) 2020(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Actavis Mid-Atlantic, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 28. Actavis Mid-Atlantic, LLC (United States) Revenue: by Geography 2020
  • Figure 29. Pfizer pharmaceuticals Ltd (United States) Revenue, Net Income and Gross profit
  • Figure 30. Pfizer pharmaceuticals Ltd (United States) Revenue: by Geography 2020
  • Figure 31. Sun pharmaceutical industries Ltd (India) Revenue, Net Income and Gross profit
  • Figure 32. Sun pharmaceutical industries Ltd (India) Revenue: by Geography 2020
  • Figure 33. Wockhardt Ltd (India) Revenue, Net Income and Gross profit
  • Figure 34. Wockhardt Ltd (India) Revenue: by Geography 2020
  • Figure 35. Watson Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Watson Laboratories, Inc. (United States) Revenue: by Geography 2020
  • Figure 37. Pharmeral Inc (United States) Revenue, Net Income and Gross profit
  • Figure 38. Pharmeral Inc (United States) Revenue: by Geography 2020
  • Figure 39. APP Pharmaceuticals, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 40. APP Pharmaceuticals, LLC (United States) Revenue: by Geography 2020
  • Figure 41. Baxter International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Baxter International Inc. (United States) Revenue: by Geography 2020
  • Figure 43. Hospira (United States) Revenue, Net Income and Gross profit
  • Figure 44. Hospira (United States) Revenue: by Geography 2020
  • Figure 45. Mylan N.V. (United States) Revenue, Net Income and Gross profit
  • Figure 46. Mylan N.V. (United States) Revenue: by Geography 2020
  • Figure 47. Global Phenytoin: by Type USD Million (2021-2026)
  • Figure 48. Global Phenytoin: by Application USD Million (2021-2026)
  • Figure 49. Global Phenytoin: by Distribution Channel USD Million (2021-2026)
  • Figure 50. Global Phenytoin: by End-user USD Million (2021-2026)
  • Figure 51. South America Phenytoin Share (%), by Country
  • Figure 52. Asia Pacific Phenytoin Share (%), by Country
  • Figure 53. Europe Phenytoin Share (%), by Country
  • Figure 54. MEA Phenytoin Share (%), by Country
  • Figure 55. North America Phenytoin Share (%), by Country
  • Figure 56. Global Phenytoin: by Type K Units (2021-2026)
  • Figure 57. Global Phenytoin: by Application K Units (2021-2026)
  • Figure 58. Global Phenytoin: by Distribution Channel K Units (2021-2026)
  • Figure 59. Global Phenytoin: by End-user K Units (2021-2026)
  • Figure 60. South America Phenytoin Share (%), by Country
  • Figure 61. Asia Pacific Phenytoin Share (%), by Country
  • Figure 62. Europe Phenytoin Share (%), by Country
  • Figure 63. MEA Phenytoin Share (%), by Country
  • Figure 64. North America Phenytoin Share (%), by Country
  • Figure 65. Global Phenytoin: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Actavis Mid-Atlantic, LLC (United States)
  • Pfizer pharmaceuticals Ltd (United States)
  • Sun pharmaceutical industries Ltd (India)
  • Wockhardt Ltd (India)
  • Watson Laboratories, Inc. (United States)
  • Pharmeral Inc (United States)
  • APP Pharmaceuticals, LLC (United States)
  • Baxter International Inc. (United States)
  • Hospira (United States)
  • Mylan N.V. (United States)
Select User Access Type

Key Highlights of Report


Mar 2021 200 Pages 88 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Phenytoin Market Quantitative research analysis
Global Phenytoin Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increased Prevalence of Seizures among People " is seen as one of major growth factors of Phenytoin Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

Know More About Global Phenytoin Market Report?

Have a Query? Click Here

Other Related Reports

Fluphenazine Decanoate Comprehensive Study by Application (Acute Schizophrenia, Chronic Schizophrenia, Others), Sales Channel (Hospital Pharmacy, Retail Pharmacy, Other), End User (Children, Adult) P...
$ 3500
Antiparasitic Drugs Comprehensive Study by Type (Anthelmintics (Benzimidazole, Ivermectin, Pyrantel), Scabicides and Pediculicides (Lindane, Benzyl Benzoate), Antiprotozoals (Chloroquine, Pyrimethami...
$ 3750
Dong Quai  Comprehensive Study by Type (Liquid, Tablets, Capsules, Tinctures, Tea, Topical creams, Powders), Application (Allergies, Headache, Premenstrual syndrome, Menstrual cramps, Fibroids, Nas...
$ 3650
Thiamazole Comprehensive Study by Application (Adults, Children), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), Thyroid Hormones Type (T3, T4), Strength (5 mg, 10 ...
$ 3500
Rectocele Treatment Comprehensive Study by Treatment (Surgical (Rectocele Repair Surgery), Non-Surgical (Floor Exercise, Pessary)), Diagnosis (Physical Test, Defecography, Imaging tests, Other tests)...
$ 3450
Calcitonin Salmon Comprehensive Study by Application (Osteoporosis, Paget's Disease, Hypercalcemia), Route of Administration (Injection, Nasal Spray), Distribution Channel (Hospital Pharmacies, Retai...
$ 3350